Key statistics
As of last trade Labcorp Holdings Inc (LH:NYQ) traded at 239.95, -3.24% below its 52-week high of 247.99, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 240.22 |
---|---|
High | 240.97 |
Low | 239.05 |
Bid | 239.77 |
Offer | 240.13 |
Previous close | 240.17 |
Average volume | 785.69k |
---|---|
Shares outstanding | 83.64m |
Free float | 83.36m |
P/E (TTM) | 46.54 |
Market cap | 20.09bn USD |
EPS (TTM) | 5.16 USD |
Annual div (ADY) | 2.88 USD |
---|---|
Annual div yield (ADY) | 1.20% |
Div ex-date | Aug 29 2024 |
Div pay-date | Sep 13 2024 |
Next div ex-date | Nov 26 2024 |
Next div pay-date | Dec 13 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 17:10 GMT.
More ▼
- Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
- Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors
- NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
- Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer